Sunitinib Not Indicated for Prostate Cancer
Links shared publicly online about this topic
No Prostate Cancer Indication for Sunitinib - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- A phase IIIa trial of the tyrosine kinase inhibitor sunitinib (Sutent) in patients with advanced castration-resistant prostate cancer has been halted for lack of efficacy, the drug's manufacturer announced.” View full resource at qualitypointtech.net
Most Recently Shared on September 28, 2010 at 5:00 pm By:
No Prostate Cancer Indication for Sunitinib: (MedPage Today) -- A phase IIIa trial of the tyrosine kinase inhibito... http://bit.ly/cLtUIL
Prostate cancer may be caused by virus, study indicates
physorg.com — “Mounting evidence indicates that prostate cancer is an infectious disease caused by a recently identified virus.” View full resource at physorg.com
Most Recently Shared on September 18, 2009 at 3:19 pm By:
Prostate cancer may be caused by virus, study indicates http://bit.ly/2Gco3a
Prostate cancer statistics indicate early detection
fremonttribune.com — “Prostate cancer is found more often on average in the Three Rivers Health Department District than in the rest of” View full resource at fremonttribune.com
Most Recently Shared on October 23, 2010 at 8:33 am By:
Prostate cancer statistics indicate early detection http://bit.ly/aifm8V
Hsp-27 protein: An indicator of prostate cancer progression
news-medical.net — “In the largest study of its kind, the international team of pathologists studied an initial 4,000 prostate cancer patients over a period of 15 years to further understanding into the natural progression of the disease and how it should be managed. The research, published in the British Journal of Cancer, could be used to develop a blood test to distinguish between aggressive and non-aggressive forms of prostate cancer.” View full resource at news-medical.net
Most Recently Shared on September 24, 2009 at 1:03 pm By:
Prostate Cancer: Hsp-27 protein: An indicator of prostate cancer progression: In the largest stu.. http://bit.ly/3Q3b7D
Indication Of Considerable Added Benefit From Abiraterone In Certain Prostate Cancer Patients
medicalnewstoday.com — “Advantages for men with metastatic hormone-refractory prostate cancer who are no longer eligible for docetaxel therapy Abiraterone (trade name: Zytiga®) has been approved sinc” View full resource at medicalnewstoday.com
Most Recently Shared on January 10, 2012 at 8:05 am By:
Indication Of Considerable Added Benefit From Abiraterone In Certain Prostate Cancer Patients http://t.co/WSFtHDef #prostate
Protein Spikes Not a Lone Indicator for Prostate Cancer Detection | ThirdAge
thirdage.com — “A protein spike of prostate specific antigen (PSA) is not a reliable indicator for prostate cancer detection. A medical research study centered in the United States analyzed 5,000 men and their PSA levels, and then tested for prostate cancer to determine” View full resource at thirdage.com
Most Recently Shared on February 25, 2011 at 9:38 pm By:
Protein Spikes Not a Lone Indicator for Prostate Cancer Detection http://bit.ly/h9XZJP
Prostate Cancer and Pancreatic Cancer: New Studies Indicate Improvement with PC Hope | Only Prostate Cancer
onlyprostatecancer.com — “Prostate Cancer and Pancreatic Cancer: New Studies Indicate Improvement with PC Hope | Only Prostate Cancer” View full resource at onlyprostatecancer.com
Most Recently Shared on January 4, 2011 at 3:51 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Prostate Cancer and Pancreatic Cancer: New Studies Indicate Improvement with PC Hope: (PRWEB) December 9, 2004... http://bit.ly/eX7QJN
ITG's Majestic Market Research Prostate Cancer Study Indicates... - Topix
topix.com — “ITG's Majestic Market Research Prostate Cancer Study Indicates... - Topix” View full resource at topix.com
Most Recently Shared on March 23, 2011 at 12:33 am By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
ITG's Majestic Market Research Prostate Cancer Study Indicates...: ITG's Majestic Market Research Prostate Cance... http://bit.ly/g9fayY
Hand Size May Indicate Risk For Prostate Cancer | NBC 4i
www2.nbc4i.com — “Experts say you may be able to look at a man's hands to determine his risk for prostate cancer.” View full resource at www2.nbc4i.com
Most Recently Shared on January 3, 2011 at 12:09 pm By:
john clay mchugh Surgeon, Urologist, Physician, and Doctor
Study: Hand Size May Indicate Risk For Prostate Cancer: Experts say you may be able to look at a man's hands to ... http://bit.ly/hAVSTP
New Study Indicates Running Reduces Prostate Cancer Risk
running.competitor.com — “A new joint study between Harvard University and The University of California-San Francisco has found that minimal amounts of exercise reduces the ris” View full resource at running.competitor.com
Most Recently Shared on January 7, 2011 at 4:58 pm By:
Study Indicates Running Reduces Prostate Cancer Risk http://bit.ly/fbfSDZ
Early balding shown to indicate increased prostate cancer risk
privatemdlabs.com — “Order lab tests online safely and securely. Tests include STD tests, Male and Female Adult Wellness tests, Cholesterol tests and more.” View full resource at privatemdlabs.com
Most Recently Shared on February 18, 2011 at 1:11 pm By:
Early balding shown to indicate increased prostate cancer risk http://bit.ly/i5p10Z
Lose Fat Advice » Blog Archive » Prostate Cancer Test Indicates Treatment Options And Prostate Cancer Recurrence.
turbulencetrainingxp.com — “Lose Fat Advice » Blog Archive » Prostate Cancer Test Indicates Treatment Options And Prostate Cancer Recurrence.” View full resource at turbulencetrainingxp.com
Most Recently Shared on May 8, 2010 at 3:56 am By:
Lose Fat Advice » Blog Archive » Prostate Cancer Test Indicates ... http://bit.ly/ah3dNT
SUTENT(R) (Sunitinib) Receives European Approval For A New Indication In Progressive Pancreatic Neuroendocrine Tumours (NET)
medicalnewstoday.com — “Pfizer Ltd announced that the European Commission has approved SUTENT® (sunitinib malate) for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours” View full resource at medicalnewstoday.com
Most Recently Shared on December 16, 2010 at 1:05 pm By:
SUTENT(R) (Sunitinib) Receives European Approval For A New Indication In Progressive Pancreatic Neuroendocrine Tumours... http://mnt.to/3P4R
Determiner for Agressive Prostate Cancer
medindia.net — “A determiner that indicates prostate cancer aggressiveness has been discovered by researchers who believe that this will lead to better diagnosis and treatment.” View full resource at medindia.net
Most Recently Shared on July 14, 2010 at 5:47 pm By:
Determiner for Agressive Prostate Cancer http://bit.ly/dde4VL
Study: PSA Levels Not the Best Prostate Cancer Indicator - FoxNews.com
foxnews.com — “Men over the age of 50 usually get prostate-specific antigen blood tests, but doctors are now saying PSA levels are not the best indicators for whether or not a man has prostate cancer” View full resource at foxnews.com
Most Recently Shared on February 25, 2011 at 11:49 pm By:
Health,Fitness,Diet Health Business
Study: PSA Levels Not the Best Prostate Cancer Indicator http://bit.ly/eb5ijO
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MedicalFeed
Medical news and updates about medical articles and discussion in Google knols and in many medical websites.
-
FightCancer
Cancer news feed, formerly part of a blog. RSS suggestions welcome.
-
Prostate Cancer
You just hit the official Twitter Page of Prostate Cancer Community! We have the info you need when it come to Prostate Cancer. Dive in and get connected!
Advertisement
